
Metabolic Meds Startup Verdiva Launches With $411M and a Weekly Oral GLP-1 Drug
Published on January 9, 2025
receptors. Verdiva’s Series A round was co-led by Forbion and General Atlantic. Other participants in the financing include RA Capital

receptors. Verdiva’s Series A round was co-led by Forbion and General Atlantic. Other participants in the financing include RA Capital